EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSPLAG00000023411
Gene Symbol: KCNQ5
3 Cross references
196 Possible Orthologues:

Potassium Voltage-Gated Channel, Kqt-Like Subfamily, Member 2a

Ensembl ID : ENSPLAG00000002311
Gene Symbol: KCNQ2A
1 Cross references
185 Possible Orthologues:

Potassium/sodium Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4-Like

Ensembl ID : ENSPLAG00000007394
Gene Symbol: LOC106942713
2 Cross references
212 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSPLAG00000004459
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSPLAG00000020863
Gene Symbol: LOC106951976
3 Cross references
200 Possible Orthologues:

Presenilin-2-Like

Ensembl ID : ENSPLAG00000019079
Gene Symbol: LOC106942401
3 Cross references
205 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSPLAG00000000977
Gene Symbol: LOC106953921
3 Cross references
397 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPLAG00000004732
Gene Symbol: LOC106953123
3 Cross references
250 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPLAG00000010071
Gene Symbol: LOC106951736
3 Cross references
255 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSPLAG00000011667
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prokineticin Receptor 2

Ensembl ID : ENSPLAG00000016954
Gene Symbol: PROKR2
3 Cross references
215 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPLAG00000011856
Gene Symbol: PTGDR2
2 Cross references
135 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).